Capital International Investors grew its position in Qiagen N.V. (NYSE:QGEN – Free Report) by 11.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,587,505 shares of the company’s stock after purchasing an additional 264,412 shares during the period. Capital International Investors’ holdings in Qiagen were […]

Capital International Investors lowered its position in BBB Foods Inc. (NYSE:TBBB – Free Report) by 34.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,233,214 shares of the company’s stock after selling 2,271,974 shares during the quarter. Capital International Investors’ holdings in BBB […]

Capital International Investors lifted its position in shares of SPDR Bloomberg 1-3 Month T-Bill ETF (NYSEARCA:BIL – Free Report) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,190,426 shares of the company’s stock after acquiring an additional […]

Capital International Investors grew its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 14.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,104,309 shares of the biopharmaceutical company’s stock after purchasing an additional 3,891,615 shares during the period. Capital International Investors […]